More on KLRA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (9/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NQ:KLRA)
Delayed: 21.61 +1.71 (8.59%)
Prev. Close $19.90  
Open$20.12 
52 Wk High$ 
52 Wk Low$ 
Day High$21.83 
Day Low$20.12 
P/E N/A  
EPS$ 
Volume194,367 

Friends, Peers and Foes (?): MBX PFE (more...)

Jun 11, 2026 04:05 PM Form 4 Kailera Therapeutics, For: Jun 09 Filed by: Renaud Ronald C JR
Jun 5, 2026 07:32 PM Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026
May 28, 2026 04:05 PM Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
May 26, 2026 04:41 PM Form 10-Q Kailera Therapeutics, For: Mar 31
May 26, 2026 04:33 PM Form 8-K Kailera Therapeutics, For: May 26
May 26, 2026 04:02 PM Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates
May 13, 2026 07:30 AM Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions
May 12, 2026 06:32 AM Evercore ISI Starts Kailera Therapeutics (KLRA) at Outperform
May 12, 2026 06:07 AM Leerink Partners Starts Kailera Therapeutics (KLRA) at Outperform
May 12, 2026 05:37 AM MBX Biosciences (MBX) PT Raised to $86 at Citizens on 'Good' MBX 4291 Update
View All Articles

Entities mentioned with KLRA

View All Entities